ARCHIVES

Newell Reports Cancer Deaths In Younger Age Groups Dropping

This article is from The Cancer Letter archive.

Vol. 03 No. 11 | March 18, 1977

Download PDF Visit The Full Archive

Related Articles

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

Planned Parenthood May Be Doing Harm By Selling Breast Cancer Screening to Women Under 40

February 10, 2012

Treatment Division Outlines Future Program Areas

January 24, 1975

Proposed Regulations for Center Grants In Federal Register

October 29, 1976

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004